2. NCI Benchmarks » malignant tumors
http://benchmarks.cancer.gov/2010/08/scientists-develop-model-that-advances-understanding-of-the-process-of-cancer-metastasis/#comments
Nat\'l Cancer Institute

3. SEER Training: Non-malignant Brain Tumors
On January 1, 2004, all cancer registrars in the United States will begin to identify and abstract benign and borderline tumors of the brain and central nervous system.
Nat\'l Cancer Institute

4. SEER Training: Review: Non-malignant Brain Tumors
The major rationale for making benign and borderline CNS tumors reportable is: Benign and borderline CNS tumors cause disruption of normal function similar to that caused by malignant CNS tumors. Location of a CNS tumor<...
Nat\'l Cancer Institute

5. Ovarian Low Malignant Potential Tumors Treatment (PDQ®): Treatment - Health Professional Information [NCI]
This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the treatment of ovarian low malignant potential tumors. This summary is reviewed regularly and updated as necessa...
Healthline.com (OMS Preferred Provider)

6. Malignant Tumor
One component of the Department of Neurosurgery is the weekly Tumor Board meeting. A comprehensive specialty team of neurosurgeons, medical oncologists, radiation oncologists, neurologists, neuroradiologists, pediatric oncologists, neuro-oncologis...
www.cedars-sinai.edu

7. Index of /html
Index of /html
www.agsdus.org

8. Malignant Bone Tumors
Malignant bone tumors are much less common than benign tumors. They are also much more dangerous. The term "malignant" indicates that there is moderate to high probability that the tumor will spread beyond...
my.clevelandclinic.org

9. Malignant Nerve Sheath Tumors
Malignant nerve sheath tumors (MNST) occur along the sheaths that surround peripheral nerves. This classification includes tumors previously called malignant schwannoma, malignant neurofibroma, nerve sheath...
neurosurgery.ucla.edu

10. Malignant Mixed Tumors
Accounts for about 6% of all salivary gland tumors. It is a malignant epithelial tumor arising in or from a benign mixed tumor. The carcinomatous component in most instances is adenocarcinoma.
www.pathnet.medsch.ucla.edu